Ascendis Health Shares Outstanding vs. Revenue

ASC Stock   74.00  3.00  4.23%   
Considering the key profitability indicators obtained from Ascendis Health's historical financial statements, Ascendis Health may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Ascendis Health's ability to earn profits and add value for shareholders.
For Ascendis Health profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Ascendis Health to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Ascendis Health utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Ascendis Health's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Ascendis Health over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Ascendis Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ascendis Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ascendis Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Ascendis Health Revenue vs. Shares Outstanding Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Ascendis Health's current stock value. Our valuation model uses many indicators to compare Ascendis Health value to that of its competitors to determine the firm's financial worth.
Ascendis Health is number one stock in shares outstanding category among its peers. It also is the top company in revenue category among its peers totaling about  3.20  of Revenue per Shares Outstanding. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ascendis Health's earnings, one of the primary drivers of an investment's value.

Ascendis Revenue vs. Shares Outstanding

Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Ascendis Health

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
487.45 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Ascendis Health

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
1.56 B
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Ascendis Revenue vs Competition

Ascendis Health is the top company in revenue category among its peers. Market size based on revenue of Drug Manufacturers-Specialty & Generic industry is presently estimated at about 52.79 Billion. Ascendis Health holds roughly 1.56 Billion in revenue claiming about 2.95% of equities under Drug Manufacturers-Specialty & Generic industry.

Ascendis Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Ascendis Health. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Ascendis Health position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Ascendis Health's important profitability drivers and their relationship over time.

Use Ascendis Health in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ascendis Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascendis Health will appreciate offsetting losses from the drop in the long position's value.

Ascendis Health Pair Trading

Ascendis Health Pair Trading Analysis

The ability to find closely correlated positions to Ascendis Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ascendis Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ascendis Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ascendis Health to buy it.
The correlation of Ascendis Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ascendis Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ascendis Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ascendis Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Ascendis Health position

In addition to having Ascendis Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Pharmaceutical Products Thematic Idea Now

Pharmaceutical Products
Pharmaceutical Products Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Pharmaceutical Products theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Pharmaceutical Products Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Ascendis Stock

To fully project Ascendis Health's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Ascendis Health at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Ascendis Health's income statement, its balance sheet, and the statement of cash flows.
Potential Ascendis Health investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Ascendis Health investors may work on each financial statement separately, they are all related. The changes in Ascendis Health's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Ascendis Health's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.